← FDA Drug Approvals (Drugs@FDA)
BAXFENDY
NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2026-05-15
Drug application
- FDA Application #
NDA219878- Application type
- New Drug Application
- Brand name
- BAXFENDY
- Generic name
- Baxdrostat
- Active ingredients
- BAXDROSTAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- First approval
- 2026-05-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown